drugset / Trial / NCT03830827
MBRP + Vortioxetine VS MBRP on Preventing Relapse in Chronic MA Users
Phase 4
Unknown
220 enrolled
Sir Run Run Shaw Hospital
Huazhong University of Science and Technology · collabShenzhen Mental Health Center · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This multicenter, double-blind, Randomized, parallel-group study in subjects with methamphetamine dependence was to assess the efficacy of MBRP combined with vortioxetine and MBRP alone on 24-week abstinence rates, improvement of cognition and depressive symptoms.
Timeline
- Start
- 2020-09-01
- Primary completion
- 2021-04-30
- Completion
- 2021-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vortioxetine | Unknown | 10 mg | — |
| Subject | Vortioxetine | Unknown | 20 mg | — |